Download PDF

1. Company Snapshot

1.a. Company Description

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company.Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test.The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem.


Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Show Full description

1.b. Last Insights on PRE

Prenetics Global Limited's recent performance was negatively impacted by a lack of significant earnings-related news. The company's fourth quarter and full year 2024 financial results, announced on March 5, 2025, showed revenue growth, but the report was overshadowed by the absence of any substantial guidance or forward-looking statements. Furthermore, the company's recent partnerships and collaborations, such as the genomics-based partnership with Humanity Protocol, have not generated significant buzz or attention. Additionally, the company's expansion of its scientific advisory board, announced on March 18, 2025, may not have a direct impact on the company's short-term performance.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

Prenetics Announces Upcoming Conference Participation

Nov -25

Source: globenewswire.com

Card image cap

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Nov -24

Source: globenewswire.com

Card image cap

H&M LAUNCHES NEW CONCEPT STORE IN BEVERLY HILLS, INTRODUCING H&M PRE-LOVED TO L.A.

Nov -21

Source: prnewswire.com

Card image cap

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Nov -14

Source: globenewswire.com

Card image cap

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

Nov -10

Source: globenewswire.com

Card image cap

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

Nov -04

Source: globenewswire.com

Card image cap

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

Oct -31

Source: globenewswire.com

Card image cap

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Oct -29

Source: globenewswire.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (10.64%)

6. Segments

Diagnostics

Expected Growth: 10.9%

Prenetics Global Limited's diagnostics segment growth of 10.9% is driven by increasing demand for genetic testing, expansion into new markets, strategic partnerships, and investments in AI-powered diagnostics. Additionally, growing awareness of personalized medicine and preventive healthcare are contributing to the segment's growth.

Prevention

Expected Growth: 9.95%

Prenetics Global Limited's 9.95% growth is driven by increasing demand for preventive healthcare, expansion into new markets, strategic partnerships, and investments in AI-powered diagnostics. Additionally, growing awareness of genetic testing and early disease detection, coupled with government initiatives promoting preventive care, contribute to the company's rapid growth.

7. Detailed Products

Circle DNA Testing

A genetic testing platform that provides insights into an individual's genetic predispositions, ancestry, and traits.

Circle Medical Testing

A range of medical tests for health and wellness, including COVID-19 testing, sexual health testing, and general health checks.

Circle Health Platform

A digital health platform that connects users with healthcare professionals, provides personalized health advice, and tracks health metrics.

Circle At-Home Testing

A range of at-home testing kits for health and wellness, including COVID-19 testing, sexual health testing, and general health checks.

Circle Wellness Programs

Personalized wellness programs that provide guidance on nutrition, fitness, and stress management.

8. Prenetics Global Limited's Porter Forces

Forces Ranking

Threat Of Substitutes

Prenetics Global Limited operates in the healthcare industry, which has a moderate threat of substitutes. While there are alternative healthcare services available, Prenetics' unique genetic testing and digital health platform provides a differentiated offering that reduces the threat of substitutes.

Bargaining Power Of Customers

Prenetics Global Limited's customers are primarily individuals seeking genetic testing and digital health services. The company's strong brand reputation and unique offerings reduce the bargaining power of customers.

Bargaining Power Of Suppliers

Prenetics Global Limited relies on suppliers for genetic testing kits and other medical equipment. While there are some alternative suppliers available, the company's dependence on these suppliers gives them some bargaining power.

Threat Of New Entrants

The genetic testing and digital health industry is rapidly evolving, and new entrants can easily disrupt the market. Prenetics Global Limited must continuously innovate and improve its offerings to stay ahead of new competitors.

Intensity Of Rivalry

The healthcare industry is highly competitive, and Prenetics Global Limited faces intense rivalry from established players and new entrants. The company must focus on differentiating its offerings and providing exceptional customer service to maintain its market share.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 1.14%
Debt Cost 3.95%
Equity Weight 98.86%
Equity Cost 2.53%
WACC 2.55%
Leverage 1.15%

11. Quality Control: Prenetics Global Limited passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Prenetics Global

A-Score: 4.8/10

Value: 7.6

Growth: 3.4

Quality: 4.1

Yield: 0.0

Momentum: 10.0

Volatility: 3.7

1-Year Total Return ->

View Full Report
Stock-Card
BioNexus Gene Lab

A-Score: 4.1/10

Value: 8.0

Growth: 2.8

Quality: 4.8

Yield: 0.0

Momentum: 8.5

Volatility: 0.3

1-Year Total Return ->

View Full Report
Stock-Card
Castle Biosciences

A-Score: 3.5/10

Value: 4.8

Growth: 8.2

Quality: 5.2

Yield: 0.0

Momentum: 1.0

Volatility: 2.0

1-Year Total Return ->

View Full Report
Stock-Card
Qilian International Holding

A-Score: 3.3/10

Value: 7.5

Growth: 3.0

Quality: 3.4

Yield: 0.0

Momentum: 6.0

Volatility: 0.0

1-Year Total Return ->

View Full Report
Stock-Card
Biodesix

A-Score: 2.7/10

Value: 7.6

Growth: 4.2

Quality: 3.8

Yield: 0.0

Momentum: 0.0

Volatility: 0.7

1-Year Total Return ->

View Full Report
Stock-Card
Selvita

A-Score: 2.3/10

Value: 3.5

Growth: 4.9

Quality: 3.7

Yield: 0.0

Momentum: 0.0

Volatility: 2.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

13.99$

Current Price

13.99$

Potential

-0.00%

Expected Cash-Flows